Abstract: In a collection of 58 snakes comprising predominantly Eurasian vipers in Switzerland, five snakes died unexpectedly during hibernation from 2009 to 2012. In one snake, organisms resembling chlamydiae were detected by immunohistochemistry in multiple histiocytic granulomas. Real-time quantitative PCR and microarray analysis were used to determine the presence of Chlamydia pneumoniae in tissue samples and cloacal/choanal swabs from snakes in the collection; 8/53 (15.1%) of the remaining snakes were positive. Although one infected snake had suppurative periglossitis, infection with C. pneumoniae did not appear to be associated with specific clinical signs in snakes. Of seven snakes treated with 5 mg/kg marbofloxacin IM once daily, five became PCR negative for C. pneumoniae following treatment, whereas one animal remained positive and one snake was lost to follow-up. 
Although one infected snake had suppurative periglossitis, infection with C. pneumoniae did 40 not appear to be associated with specific clinical signs in snakes. Of seven snakes treated with 41 5 mg/kg marbofloxacin IM once daily, five became PCR negative for C. pneumoniae 42 following treatment, whereas one animal remained positive and one snake was lost to follow-43
up. 44 45
Keywords: Chlamydia pneumoniae; Snake; Diagnosis; Treatment; Marbofloxacin 46 47 disease and has been reported in horses, marsupials, amphibians and reptiles (Roulis et al., 48 2013) . Whilst much is known about the symptoms and treatment of C. pneumoniae in 49 humans, there are few reports of chlamydiae in reptiles (Jacobson et al., 2004; Soldati et al., 50 2004; Frutos et al., 2014) . C. pneumoniae has been identified in granulomatous lesions in 51 squamata (Jacobson et al., 2004; Soldati et al., 2004) , but the pathogenicity of this agent 52 remains unclear. Here, we report the detection of C. pneumoniae in a private collection of 53 snakes, comprising Viperidae, Colubridae, Pythonidae and Elapidae, along with the 54 diagnostic and therapeutic protocol adopted. Table 1) . On pathological 58 examination, a 2.5 year old female horned viper (Vipera ammodytes ammodytes) had 59 multifocal histiocytic granulomas in the large blood vessels proximal to the cardiac atrium 60 (Fig. 1a) and in the liver and splenopancreas. Occasional presumptive chlamydial inclusion 61 bodies were detected in histiocytes in sections stained with haematoxylin and eosin, and the 62 presence of Chlamydia was confirmed by immunohistochemistry using a Chlamydiaceae 63
Family-specific monoclonal antibody directed against the chlamydial lipopolysaccharide 64 (ACI-P, Progen Biotechnik; Fig. 1b) (Soldati et al. 2004 ). Samples of lung, heart, liver, 65 splenopancreas, kidney and intestine were tested using a Chlamydiaceae Family-specific real-66 time quantitative PCR (qPCR) and C. pneumoniae was identified using an ArrayTube 67 microarray (Borel et al., 2008) . Chlamydial infection was postulated as most likely cause of 68 death in this snake. The other four snakes were negative for Chlamydiaceae by qPCR and did 69 not have consistent lesions at postmortem examination (see Appendix: Supplementary Table  70 1). 71
72
Choanal/cloacal swabs from six snakes that had either direct or indirect (fomite) 73 contact with the index case were positive for C. pneumoniae by qPCR-microarray. The 74 remaining 47 animals in the collection were also tested. In total, C. pneumoniae was detected 75 in choanal/cloacal swabs from 8/53 (15%) live snakes ( Table 1 ). All samples were negative 76 by virus isolation and PCR for paramyxoviruses and adenoviruses (Blahak, 1995) . Four 77 months after the first screening, the eight C. pneumoniae positive snakes, along with one 78 previously negative snake sharing a cage with a positive animal, and one snake that was 79 positive for a Chlamydiaceae (not C. pneumoniae), were retested by qPCR-microarray. While 80 3/8 previously positive snakes became C. pneumoniae negative, the previously negative snake 81 sharing a cage with a positive animal became positive for C. pneumoniae. 82
83
Marbofloxacin was selected in an attempt to eradicate C. pneumoniae from the 84 collection, since quinolones are used frequently in reptiles and have been shown to be 100% 85 inhibitory for C. pneumoniae in vitro (Hammerschlag and Roblin, 2000) . The seven 86 remaining positive snakes were treated with 5 mg/kg marbofloxacin (Marbocyl FD, 87 Vétoquinol AG) IM once daily (Table 2) . Choanal/cloacal swabs were tested for chlamydiae 88 by qPCR at the onset of treatment and every 5 days until day 35. Treatment was discontinued 89 as soon as all snakes in the same terrarium became qPCR negative or no later than day 35 for 90 all the other snakes, since hibernation was scheduled for day 95. At day 35, 3/7 treated snakes 91 were negative by qPCR for all Chlamydiaceae, one snake remained positive for C. 92 pneumoniae, one snake was positive for Chlamydiaceae (not C. pneumoniae), no sample was 93 collected from one animal and one snake was sold. 94
95
After hibernation (day 320), the entire collection (n = 45; no samples from two 96 animals, 12 animals sold, one animal dead due to egg retention and seven new acquisitions) 97 was retested by qPCR-microarray. The snake that had been positive for C. pneumoniae at day 98 35 of treatment tested negative for Chlamydiaceae after hibernation; this snake had a 99 suppurative inflammation of the tongue sheath at the first day of therapy, which eventually 100 healed. The snake that was positive for Chlamydiaceae but negative for C. pneumoniae on 101 day 35 remained positive after 320 days. All other snakes in the collection were negative by 102 qPCR for chlamydiae (n = 44). granulomas from dead snakes and identified chlamydiae by electron microscopy and 113 immunohistochemistry, respectively; chlamydial DNA was also detected by PCR. In our 114 investigation, C. pneumoniae was detected in 1/5 snakes that died, while none of the other 115 eight animals that were positive for C. pneumoniae died. These findings suggest that C. 116 pneumoniae infections might not be necessarily lethal for snakes and are consistent with 117 another report of clinically inconspicuous carriers (Frutos et al., 2013 
